Ameritas Investment Partners’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Ameritas Investment Partners’s Portfolio ELOX Stock Details ELOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-56	Closed	-$7K	–	3307
2021 Q1	$7K	Hold	56	–	–	﹤0.01%	2964
2020 Q4	$9K	Hold	56	–	–	﹤0.01%	2857
2020 Q3	$6K	Hold	56	–	–	﹤0.01%	2951
2020 Q2	$7K	Hold	56	–	–	﹤0.01%	2898
2020 Q1	$4K	Hold	56	–	–	﹤0.01%	2884
2019 Q4	$16K	Hold	56	–	–	﹤0.01%	2530
2019 Q3	$10K	Hold	56	–	–	﹤0.01%	2767
2019 Q2	$22K	Hold	56	–	–	﹤0.01%	2403
2019 Q1	$26K	Hold	56	–	–	﹤0.01%	2257
2018 Q4	$27K	Hold	56	–	–	﹤0.01%	2175
2018 Q3	$38K	Hold	56	–	–	﹤0.01%	2146
2018 Q2	$38K	Buy	+56	New	+$36.3K	﹤0.01%	2168

Other funds holding ELOX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Ameritas Investment Partners's ELOX Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2021, closing a stake of 56 shares — an estimated $7K sold.

Ameritas Investment Partners first reported a position in ELOX in Q2 2018 and held it in 12 quarters. The position peaked at $38K in Q3 2018. 46 funds tracked by Wall St. Rank hold ELOX as of Q2 2021.

Ameritas Investment Partners reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 56 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $7K.
Ameritas Investment Partners first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 12 quarters.
Ameritas Investment Partners's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $38K in Q3 2018.
46 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.